(1)
SINGAPORE and MELBOURNE, Australia, Feb. 2, 2021 /PRNewswire/
See-Mode Technologies, a MedTech startup based in Singapore and Australia that seeks to empower clinicians to better predict stroke, today announced that it has received two more regulatory approvals - the CE Mark and Therapeutic Goods Administration (TGA) approval for its debut product, the Augmented Vascular Analysis (AVA) software. AVA uses Artificial Intelligence (AI) to perform automated analysis and reporting of vascular ultrasound scans, enabling clinicians to interpret and report on these scans more efficiently and with higher quality.
See-Mode s AVA received FDA 510(k) clearance in 2020, and was also approved by Singapore s Health Sciences Authority (HSA) as a Class B medical device in 2019. With these four major regulatory approvals - all received within a span of three years from the inception of the company - See-Mode now has a firm foundation to rapidly scale its business across its core markets, na